FDA Approves more Manufacturer of Methoxsalen MarketWatch (press release) 15, 2012 /PRNewswire via COMTEX/ -- The FDA has authorized the addition of type A secondary supplier of Methoxsalen USP, an integral element of a treatment for the relief of average to severe psoriasis unarbitrary under the brand linguistic unit Oxsoralen-Ultra® ... and more » Link To Article
No comments:
Post a Comment